Human HIV Vaccine Trial Begins With BRILLIANT 011
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.
AI in Drug Development helps Pharma Cut Trial Admin Time
AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.
Cholera Vaccine Trial Aims for Self-Reliance in Africa
Discover the significance of the cholera vaccine trial by Biovac and the MRC in promoting health self-reliance in Africa.
Lower-Dose Immunotherapy Trials Expand Treatment Options
Explore lower-dose immunotherapy trials that show promise in enhancing cancer treatment efficacy and reducing healthcare costs.
Immunotherapy for Cancer and Early-Stage Success
Explore immunotherapy for cancer and its transformative impact on treatment at earlier stages, improving survival rates.
Are New Cancer Treatments Worth the Price?
Learn about the cost of cancer treatments and the reality behind their effectiveness. Are patients getting the care they deserve?
Medical Research in SA: The Impact of NIH Cuts
Learn about the crisis in medical research in SA from NIH funding cuts and the pivotal role of the government in recovery.
Research faces funding crisis after NIH grant cuts
South African researchers face significant funding cuts from the US National Institutes of Health (NIH), jeopardising critical HIV/AIDS and TB research.